ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) AT FLOW-CYTOMETRY

被引:52
作者
ORFAO, A
CIUDAD, J
LOPEZBERGES, MC
LOPEZ, A
VIDRIALES, B
CABALLERO, MD
VALVERDE, B
GONZALEZ, M
SANMIGUEL, JF
机构
[1] Servicio General de Citometria y Servicio de Hematologia, Universidad de Salamanca
关键词
D O I
10.3109/10428199409052682
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study the usefulness of a method combining multiple staining direct immunofluorescence technique together with flow cytometry in order to predict relapse in ALL is analyzed in a group of 47 patients (11 T-ALL and 36 B-ALL). Results show that this method can be applied to at least two-thirds of all ALL patients being specially useful for the T-ALL cases (100% vs 56%) as this corresponding to the incidence of ''aberrant'' phenotypes. The detection of an increase in the percentage of bone marrow cells displaying ''aberrant'' phenotypes in two consecutive samples from the same patient is of great help on predicting relapse (sensitivity of 92% and specificity of 75%).
引用
收藏
页码:87 / 90
页数:4
相关论文
共 30 条
[1]  
Bradstock K.F., Papageorgiou E.S., Janossy G., Diagnostic of meningeal involvement in patients with acute lymphoblastic leukemia using immunofluorescence for terminal transferase, Cancer, 47, pp. 2478-2481, (1981)
[2]  
Bradstock K.F., Janossy G., Pizzolo G., Hoffbrand A.V., McMichael A., Pilch J.R., Subpopulations of normal and leukemic human thymocytes: an analysis using monoclonal antibodies, JNCI, 65, pp. 33-38, (1980)
[3]  
Bradstock K.F., Janossy G., Tidman N., Papageorgiou E.S., Prentice H.G., Willoughby M., Immunological monitoring of minimal residual disease in treated thymic acute lymphoblastic leukemia, Leuk. Res., 5, pp. 301-309, (1981)
[4]  
van Denderen J., Hermans A., Meeuwsen T., Antibody recognition of the tumor-specific bcr-abl joining region of the chronic myeloid leukemia, J. Exp. Med., 169, pp. 87-98, (1989)
[5]  
Kamps M.P., Murre C., Sun X.H., Baltimore D., A new homeobox gene contributes the DNA binding domain of the t(1
[6]  
19) translocation protein in pre-B ALL, Cell, 60, pp. 547-556, (1990)
[7]  
Campana D., Coustan-Smith E., Behm F.G., The definition of remission in acute leukemia with immunologic techniques, Bone Marrow Transpi, 8, pp. 429-437, (1991)
[8]  
van Dongen J.J.M., Breit T.M., Adriaasen H.J., Beishuizen A., Hooijkaas H., Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction, Leukemia, 6, suppl 1, pp. 47-59, (1992)
[9]  
Greaves M.F., Differentiation-linked leukemogenesis in lymphocytes, Science, 234, pp. 697-704, (1986)
[10]  
Janossy G., Campana D., The pathophysiological basis of immunodiagnosis in acute lymphoblastic leukaemia, Cancer Res., 8, pp. 91-122, (1988)